NCT04525482View on ClinicalTrials.gov

Application of Early Goal-directed Sedation in Patients With Severe Brain Injury

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Brain Injuries, Traumatic
Interventions
OTHER

Early goal-directed sedation programs

A. Provide sedation at the beginning of the titration of dextrometomidine; b. Optimize sedation when dextrometomidine is used alone and at a maximum dose not sufficient to provide comfort and safety to the patient and to achieve a level of sedation at any time specified by the treating physician. C. Provides immediate recovery and sedation, and can control sudden agitation at any time

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT04525482 - Application of Early Goal-directed Sedation in Patients With Severe Brain Injury | Biotech Hunter | Biotech Hunter